The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
Abstract
Purpose: We have analyzed the outcome of mycosis fungoides (MF) and Sézary syndrome (SS) patients using the recent International Society for Cutaneous Lymphomas (ISCL)/European Organisation for Research and Treatment of Cancer (EORTC) revised staging proposal. Patients and Methods: Overall survival (OS), disease-specific survival (DSS), and risk of disease progression (RDP) were calculated for a cohort of 1,502 patients using univariate and multivariate models. Results: The mean age at diagnosis was 54 years, and 71% of patients presented with early-stage disease. Disease progression occurred in 34%, and 26% of patients died due to MF/SS. A significant difference in survival and progression was noted for patients with early-stage disease having patches alone (T1a/T2a) compared with those having patches and plaques (T1b/T2b). Univariate analysis established that (1) advanced skin and overall clinical stage, increased age, male sex, increased lactate dehydrogenase (LDH), and large-cell transformation were associated with reduced survival and increased RDP; (2) hypopigmented MF, MF with lymphomatoid papulosis, and poikilodermatous MF were associated with improved survival and reduced RDP; and (3) folliculotropic MF was associated with an increased RDP. Multivariate analysis established that (1) advanced skin (T) stage, the presence in peripheral blood of the tumor clone without Sézary cells (B0b), increased LDH, and folliculotropic MF were independent predictors of poor survival and increased RDP; (2) large-cell transformation and tumor distribution were independent predictors of increased RDP only; and (3) N, M, and B stages; age; male sex; and poikilodermatous MF were only significant for survival. Conclusion: This study has validated the recently proposed ISCL/EORTC staging system and identified new prognostic factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291402 · Cited by 4,949
WHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
A Prognostic Score for Advanced Hodgkin's Disease
Hasenclever, D., Diehl, V., Armitage, J. O., Assouline, D., Björkholm, M., Brusamolino, E., Canellos, G. P., Carde, P., Crowther, D., Cunningham, D., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392104 · Cited by 1,736
Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., Zackheim, H., Duvic, M., Estrach, T., Lamberg, S., et al. (2007) · Blood · doi:10.1182/blood-2007-03-055749 · Cited by 1,429
Self-citationFollicular lymphoma international prognostic index
Solal-Celigny, P. (2006) · Current Treatment Options in Oncology · doi:10.1007/s11864-006-0036-3 · Cited by 1,339
Thiers, B. H. (2008) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70989-4 · Cited by 974
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
Bradford, P. T., Devesa, S. S., Anderson, W. F., & Toro, J. R. (2009) · Blood · doi:10.1182/blood-2008-10-184168 · Cited by 709
Regulation of the Immune System by Sex Steroids*
GROSSMAN, C. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-3-435 · Cited by 667
Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.857 · Cited by 653
Follicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
Mycosis Fungoides: Disease Evolution and Prognosis of 309 Dutch Patients
van Doorn, R., Van Haselen, C. W., van Voorst Vader, P. C., Geerts, M.-L., Heule, F., de Rie, M., Steijlen, P. M., Dekker, S. K., van Vloten, W. A., & Willemze, R. (2000) · Archives of Dermatology · doi:10.1001/archderm.136.4.504 · Cited by 367
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis
Diamandidou, E., Colome-Grimmer, M., Fayad, L., Duvic, M., & Kurzrock, R. (1998) · Blood · doi:10.1182/blood.v92.4.1150 · Cited by 334
Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients
Zackheim, H. S., Amin, S., Kashani-Sabet, M., & McMillan, A. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70491-3 · Cited by 294
van Krieken, J. H. J. M., Langerak, A. W., Macintyre, E. A., Kneba, M., Hodges, E., Sanz, R. G., Morgan, G. J., Parreira, A., Molina, T. J., Cabeçadas, J., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404467 · Cited by 288
Histopathologic Staging at Initial Diagnosis of Mycosis Fungoides and the Sézary Syndrome
Sausville, E. A., Eddy, J. L., Makuch, R. W., Fischmann, A. B., Schechter, G. P., Matthews, M., GLATSTEIN, E. J., Ihde, D. C., Kaye, F., Veach, S. R., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-372 · Cited by 268
Vergier, B., Muret, A. D., Beylot-Barry, M., Vaillant, L., Ekouévi, D. K., Chêne, G., Carlotti, A., Franck, N., Dechelotte, P., Souteyrand, P., et al. (2000) · PubMed · doi:10.1182/blood.v95.7.2212 · Cited by 263
Prognostic factor analysis in mycosis fungoides/Sézary syndrome
Diamandidou, E., Colome, M., Fayad, L., Duvic, M., & Kurzrock, R. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70079-4 · Cited by 172
Fraser-Andrews, E. A., Woolford, A. J., Russell-Jones, R., Whittaker, S. J., & Seed, P. T. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00830.x · Cited by 161
Self-citationHanna, N., & Schneider, M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.974 · Cited by 149
Vidulich, K. A., Talpur, R., Bassett, R. L., & Duvic, M. A. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2009.03771.x · Cited by 115
The changing survival of patients with mycosis fungoides
Weinstock, M. A., & Reynes, J. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<208::aid-cncr28>3.0.co;2-2 · Cited by 97
Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases.
BASARAB, T., Fraser-Andrews, E. A., Orchard, G. E., Whittaker, S. J., & Russel-Jones, R. (1998) · PubMed · Cited by 88
Self-citationHrushesky, W. J. M., Gruber, S. A., Sothern, R. B., Hoffman, R., LAKATUA, D. J., Carlson, A., Cerra, F. B., & Simmons, R. L. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.15.1232 · Cited by 82
Greer, J. P., Salhany, K. E., Cousar, J. B., Fields, J. P., King, L. E., Gräber, S. E., Flexner, J. M., Stein, R. S., & Collins, R. D. (1990) · Hematological Oncology · doi:10.1002/hon.2900080406 · Cited by 73
Screpanti, I., Santoni, A., Gulino, A., et al. (1987) · Cellular Immunology · doi:10.1016/0008-8749(87)90163-8 · Cited by 62
Khamly, K., Thursfield, V. J., Fay, M. F., Desai, J., Toner, G. C., Choong, P., Ngan, S. Y., Powell, G. J., & Thomas, D. M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24376 · Cited by 35
Lai, J.-C., Wu, J. Y., Cheng, Y. W., Yeh, K. T., Wu, T. C., Chen, C., & Lee, H. (2009) · PubMed · Cited by 24
Cited by
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Willemze, R., Cerroni, L., Kempf, W., Berti, E., Facchetti, F., Swerdlow, S. H., & Jaffe, E. S. (2019) · Blood · doi:10.1182/blood-2018-11-881268 · Cited by 1,412
Kim, Y. H., Bagot, M., Pinter-Brown, L., Rook, A. H., Porcu, P., Horwitz, S. M., Whittaker, S., Tokura, Y., Vermeer, M., Zinzani, P. L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30379-6 · Cited by 669
Self-citationPrince, H. M., Kim, Y. H., Horwitz, S. M., Dummer, R., Scarisbrick, J., Quaglino, P., Zinzani, P. L., Wolter, P., Sanches, J. A., Ortiz-Romero, P. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31266-7 · Cited by 588
Self-citationTrautinger, F., Eder, J., Assaf, C., Bagot, M., Cozzio, A., Dummer, R., Gniadecki, R., Klemke, C.-D., Ortiz-Romero, P. L., Papadavid, E., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.027 · Cited by 452
Self-citationScarisbrick, J. J., Prince, H. M., Vermeer, M. H., Quaglino, P., Horwitz, S., Porcu, P., Stadler, R., Wood, G. S., Beylot-Barry, M., Pham-Ledard, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.7142 · Cited by 430
Self-citation
Metadata
- Authors
- Agar, N. S., Wedgeworth, E., Crichton, S., Mitchell, T. J., Cox, M., Ferreira, S., Robson, A., Calonje, E., Stefanato, C. M., Wain, E. M., Wilkins, B., Fields, P. A., Dean, A., Webb, K., Scarisbrick, J., Morris, S., & Whittaker, S. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-11-01
- Volume
- 28
- Issue
- 31
- Pages
- 4730-4739
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2147937827
- Cited by
- 853
- References
- 29
- FWCI
- 37.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.